The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study-Reference-Cited by-同舟云学术

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

Published:2020-07-03 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Haguet Hélène,Bouvy Céline,Delvigne Anne-Sophie,Modaffari Elise,Wannez Adeline,Sonveaux Pierre,Dogné Jean-Michel,Douxfils Jonathan

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference53 articles.

1. Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance;Aghel;Vasc. Health Risk Manag.,2017

2. Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML;Aichberger;Am. J. Hematol.,2011

3. Management of imatinib-resistant patients with chronic myeloid leukemia;Bhamidipati;Ther. Adv. Hematol.,2013

4. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance;Bixby;ASH Educ. Program Book,2009

5. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial;Brummendorf;Br. J. Haematol.,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune cell-mediated features of atherosclerosis;Frontiers in Cardiovascular Medicine;2024-08-21

2. Traduction et republication de : « Événements thromboemboliques artériels liés au cancer »;La Revue de Médecine Interne;2024-08

3. Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis;Pharmaceutics;2024-04-19

4. Endothelial function in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors is not related to cardiovascular risk assessed by SCORE2 algorithm;Polish Archives of Internal Medicine;2024-04-03

5. Case report: Three characteristics of tyrosine kinase inhibitor-associated cerebrovascular stenosis. High threshold for infarction, atypical infarct area, and vascular recoverability under the use of ponatinib;Frontiers in Stroke;2024-04-03